期刊文献+

保乳手术加综合治疗治疗乳腺癌的临床研究 被引量:1

Clinical study of breast-conserving operation for breast cancer
暂未订购
导出
摘要 目的 探讨保乳手术加综合治疗乳腺癌的手术适应证、治疗方法和疗效。方法 对 46例I~IIb 期乳腺癌施行保乳手术加术后放疗、化疗及内分泌治疗等综合治疗 (保乳组 ) ;并与同期施行改良根治术加综合治疗的 5 0例I~IIb 期乳腺癌 (对照组 )进行对比。两组患者术后均随访 0 .5~ 14年 ,平均 4年。结果 保乳组 46例双侧乳房乳头基本对称、外形丰满 ,外观优良。保乳组、对照组的平均手术时间分别为 (14 3 .7± 2 1.6)min ,(181.9± 16.0 )min ;术中平均出血量分别为 (2 42± 73 )ml ,(3 76± 5 6)ml ,手术并发症率分别为 15 .2 %,3 4.0 %;保乳组均优于对照组 (均P <0 .0 5 )。保乳组 3 ,5 ,10年期生存率分别是 96.8%,88.9%,85 .7%,总局部复发率是 6.5 %;对照组 3 ,5 ,10年期生存率分别是 97.1%,89.5 %,87.5 %,总局部复发率是 4.0 %。两组生存率和复发率比较差异无显著性(均P >0 .0 5 )。结论 临床早期乳腺癌采用保乳手术加综合治疗可以取得满意的临床疗效 ,可作为早期乳腺癌的首选治疗方法。 Objective To study the surgical indication ,the operative procedure and effect for the patients with breast cancer (BC). Methods Forty-six cases of stage I~II bBC were treated with breast-conserving surgery plus radiotherapy ,chemotherapy and endocrinetherapy postoperativly .The effect of breast-consering group was compared with BC patient (50 casesI~II b) treated by modified radical mastectomy only (comtrol group) . All cases in both aroups were followed-up for 0.5~14 years with average 4 years . Results The patients treated by breast-conserving surgery had good cosmesis effect than that in control group patients did.The 3、5、10 year′s survival rate and local recurrence were 96.8%,88.9%, 87.5 % and 6.5% in breast-conserving surgery group,and 97.1%,89.5%, 87.5 % and 4.0% in modified radical mastectomy group, respectively (all P >0.05) . Conclusions The effect of early-stage of breast cancer treatment by breast-conserving therapy plus other adjunct therapies is satisfactory . It can be as the first choice for the treatment of patients with early-stage of breast cancer.
出处 《中国普通外科杂志》 CAS CSCD 2004年第5期327-330,共4页 China Journal of General Surgery
基金 广西柳州地区地厅级科技攻关项目 (2 0 0 1 0 4 0 5)
关键词 乳腺肿瘤/外科学 保乳手术 BREAST NEOPLASMS/surg BREAST-CONSERVIGN SURGERY
  • 相关文献

参考文献6

二级参考文献12

共引文献194

同被引文献19

  • 1庞达,刘锋,薛英威,张岂凡.乳腺癌组织中CD105 mRNA的表达及其临床病理意义[J].中华肿瘤杂志,2005,27(1):38-40. 被引量:15
  • 2[4]Gwyn KM,Theriault RL.Breast cancer during pregnancy.Curr Treat Op2tions Oncol,2000,1(3):239-243
  • 3[6]Vlastos G,Rubio IT,Mirza NQ,et al.Impact of multicentricity on clinical outcome in patients with 22,N021,M0 breast cancer.Ann Surg Oncol,2000,7(8):5812587
  • 4[8]Olson JA,Morris EA,Van Zee,et al.Magnetic resonance imaging facili2tates breast conservation for occult breastcancer[J].Ann Surg Oncol,2000,7(6):411-415
  • 5[12]Mariani L,Salvadori B,Marubini E,et,al.Ten year results of a ran domized trial comparing two conservative treatment strategies for small size breast cancer.Eur J Cancer,1998,34(8):1156-1162
  • 6[13]Wingo PA,Cardinez CJ,Landis SH,et al.Long-term trends in can cer mortality in the United States,1930-1998.Cancer,2003,97(12 Suppl):3133-3175
  • 7[14]Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a ran2domized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradi2ation for the treatment of invasive breastcancer[J].N Engl J Med,2002,347(16):1233-1241
  • 8[15]Ragini Kudachadkar Ruth O'Regan.Aromatase Inhibitors as Adju vant Therapy for Postmenopausal Patients With Early Stage Breast Cancer.CA Cancer J Clin,2005,55:145-163
  • 9[16]Ruo Redda MG,Verna R,Guarneri A,et al.Timing of radio 2 therapy in breast cancer conserving treatment.Cancer Treat Rev,2002,28(1):5-10
  • 10[19]Lee JM,Orel SG,Czerniecl ki BJ,et al.MRI before reexcision surgery in patients with breast cancer.A JR Am J Roentgenol,2004,182(2):437-480

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部